Drugs / SIILPCV10
last change Dec 2019 re-read 2 minutes ago

SIILPCV10

also known as SIIPL-PCV

Vaccine

Developed for
pneumococcal infection
Investigated by
PATH

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02308540 Jan 2015 → Apr 2016 pneumococcal infection PATH Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as SIIL PCV10 “Infants SIIL PCV10NCT02308540
1

NCT02308540

Known as SIIPL-PCV “Serum Institute of India Pvt. Ltd.'s PCV candidate (SIIPL-PCV) has the potential to meet this need” PMID 31843266 Dec 2019
Modality Vaccine “10-valent Pneumococcal Conjugate VaccineNCT02308540